Redpoint Investment Management Pty Ltd raised its stake in Colgate-Palmolive (NYSE:CL) by 4.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 20,906 shares of the company’s stock after purchasing an additional 872 shares during the quarter. Redpoint Investment Management Pty Ltd’s holdings in Colgate-Palmolive were worth $1,788,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in CL. Evolution Wealth Advisors LLC boosted its holdings in shares of Colgate-Palmolive by 158.4% in the 3rd quarter. Evolution Wealth Advisors LLC now owns 323 shares of the company’s stock valued at $25,000 after purchasing an additional 198 shares during the last quarter. Newfound Research LLC acquired a new position in shares of Colgate-Palmolive during the 3rd quarter valued at $28,000. Advisory Alpha LLC acquired a new position in shares of Colgate-Palmolive during the 3rd quarter valued at $28,000. Horan Capital Advisors LLC. acquired a new position in shares of Colgate-Palmolive during the 3rd quarter valued at $33,000. Finally, McIlrath & Eck LLC acquired a new position in shares of Colgate-Palmolive during the 3rd quarter valued at $44,000. Institutional investors own 76.47% of the company’s stock.

In related news, CFO Henning I. Jakobsen sold 145,280 shares of the business’s stock in a transaction dated Wednesday, November 4th. The shares were sold at an average price of $85.22, for a total transaction of $12,380,761.60. Following the completion of the sale, the chief financial officer now owns 79,756 shares of the company’s stock, valued at approximately $6,796,806.32. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director John T. Cahill sold 5,583 shares of the business’s stock in a transaction dated Wednesday, November 4th. The shares were sold at an average price of $85.31, for a total transaction of $476,285.73. Following the sale, the director now directly owns 28,594 shares of the company’s stock, valued at approximately $2,439,354.14. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 261,885 shares of company stock valued at $22,254,529. Insiders own 0.78% of the company’s stock.

CL opened at $82.49 on Thursday. The company has a 50-day moving average of $84.63 and a 200-day moving average of $79.57. The company has a market capitalization of $70.71 billion, a P/E ratio of 26.35, a PEG ratio of 4.18 and a beta of 0.59. Colgate-Palmolive has a 1-year low of $58.49 and a 1-year high of $86.41. The company has a debt-to-equity ratio of 6.50, a quick ratio of 0.62 and a current ratio of 0.97.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Wednesday, November 4th. The company reported $0.79 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.70 by $0.09. Colgate-Palmolive had a net margin of 16.65% and a return on equity of 383.88%. The company had revenue of $4.15 billion during the quarter, compared to the consensus estimate of $4 billion. During the same quarter in the previous year, the firm earned $0.71 EPS. The company’s revenue was up 5.7% on a year-over-year basis. As a group, sell-side analysts expect that Colgate-Palmolive will post 3.05 earnings per share for the current fiscal year.

Several equities analysts recently weighed in on CL shares. UBS Group lifted their target price on shares of Colgate-Palmolive from $85.00 to $90.00 and gave the company a “buy” rating in a report on Monday, November 2nd. Wells Fargo & Company started coverage on shares of Colgate-Palmolive in a report on Monday, December 7th. They set an “underweight” rating and a $80.00 target price on the stock. Truist lifted their target price on shares of Colgate-Palmolive from $80.00 to $85.00 in a report on Monday, October 26th. BidaskClub lowered shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Thursday, January 7th. Finally, Royal Bank of Canada lowered shares of Colgate-Palmolive from an “outperform” rating to a “sector perform” rating and set a $90.00 price objective on the stock. in a report on Monday, January 4th. Four equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and six have issued a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $78.58.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment products include toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items.

See Also: Dead Cat Bounce

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.